Portage Announces Conversion Of Its Debt Into Equity

Portage Biotech Inc. , is pleased to announce that its three Promissory Note holders, two of whom are the directors of Portage, who advanced opted to have their Notes and related Coupons converted into 3,500,001 restricted common shares. Notes were repayable within one year and carried 5% coupon.

http://www.biospace.com/news_story.aspx?StoryID=348288&full=1